Skip to main content
logo
Square Pharmaceuticals PLC. (DSE:SQURPHARMA)
Bangladesh flag Bangladesh · Delayed Price · Currency is BDT
219.20
-0.90 (-0.41%)
At close: Aug 13, 2026

DSE:SQURPHARMA Cash Flow Statement

Millions BDT. Fiscal year is Jul - Jun.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Net Income
25,86323,96820,92618,98018,15715,947
Depreciation & Amortization
2,2112,2012,3192,3101,8351,882
Loss (Gain) From Sale of Assets
-18.98-29.0620879.8-53.49-34.43
Loss (Gain) From Sale of Investments
127.37-----177.04
Loss (Gain) on Equity Investments
-2,695-3,194-2,595-2,523-2,011-1,291
Other Operating Activities
-6,519-5,647-4,927-4,654-3,838-3,330
Change in Accounts Receivable
2,350314.83869.7-1,262-522.93-115.84
Change in Inventory
579.61-477.05-354.95-4,177-968.71-1,558
Change in Accounts Payable
403.03-80.58453.67375.77-40.18127.76
Change in Income Taxes
----555.41338.83-405.36
Change in Other Net Operating Assets
-0.69245.581,629-29.96-22.88-69.56
Operating Cash Flow
22,30017,30218,5298,54612,87510,976
Operating Cash Flow Growth
62.50%-6.62%116.82%-33.63%17.29%2.01%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Capital Expenditures
-8,321-6,177-4,181-2,861-6,183-3,798
Sale of Property, Plant & Equipment
62.2684.1497.4478.33130.780.13
Investment in Securities
-5,730-4,124-7,221-858.01-1,416-798.2
Other Investing Activities
6,1826,3204,2564,4283,4993,239
Investing Cash Flow
-7,807-3,897-7,049787.69-3,9703,607

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Long-Term Debt Issued
---72.71,811103.71
Total Debt Issued
---72.71,811103.71
Long-Term Debt Repaid
--603.58-557.89---
Total Debt Repaid
-621.77-603.58-557.89---
Net Debt Issued (Repaid)
-621.77-603.58-557.8972.71,811103.71
Issuance of Common Stock
-----0.5
Common Dividends Paid
-10,596-9,709-9,275-8,803-5,302-3,923
Other Financing Activities
----32.23-262.5-
Financing Cash Flow
-11,218-10,313-9,833-8,762-3,754-3,819

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Foreign Exchange Rate Adjustments
63.73290.81271.89560.97447.135.61
Miscellaneous Cash Flow Adjustments
------0
Net Cash Flow
3,3393,3831,9191,1325,59810,800

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Free Cash Flow
13,97911,12514,3485,6856,6927,178
Free Cash Flow Growth
70.62%-22.46%152.37%-15.04%-6.78%-17.66%
Free Cash Flow Margin
16.73%14.58%20.47%9.37%11.62%14.16%
Free Cash Flow Per Share
15.7712.5516.186.417.558.10
Levered Free Cash Flow
9,5468,56711,4762,9484,80010,672
Unlevered Free Cash Flow
9,6198,70211,6293,0224,80010,672

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Cash Interest Paid
128.37226.55246.1487.680.030.01
Cash Income Tax Paid
4,9194,0524,3205,1274,4944,595
Change in Working Capital
3,3322.782,598-5,648-1,216-2,021